Full metadata record
DC FieldValueLanguage
dc.creatorCampión-Rodríguez, R. (Raquel)-
dc.creatorGonzalez-Navarro, C.J. (Carlos Javier)-
dc.creatorLópez, A. (Andrés)-
dc.creatorMartinez-Oharriz, C. (Cristina)-
dc.creatorMatías, C. (Cristina)-
dc.creatorSáiz-Abajo, M.J. (María José)-
dc.creatorCollantes, M. (María)-
dc.creatorPeñuelas-Sanchez, I. (Ivan)-
dc.creatorIrache, J.M. (Juan Manuel)-
dc.date.accessioned2023-09-20T10:58:36Z-
dc.date.available2023-09-20T10:58:36Z-
dc.date.issued2023-
dc.identifier.citationCampión-Rodríguez, R. (Raquel); Gonzalez-Navarro, C.J. (Carlos Javier); Martínez-López, A.L. (Ana L.); et al. "Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin". International Journal of Pharmaceutics. 643, 2023, 123216es_ES
dc.identifier.issn1873-3476-
dc.identifier.urihttps://hdl.handle.net/10171/67256-
dc.description.abstractIn this study, the ability of zein nanospheres (NS) and zein nanocapsules containing wheat germ oil (NC) to enhance the bioavailability and efficacy of quercetin was evaluated. Both types of nanocarriers had similar physico-chemical properties, including size (between 230 and 250 nm), spherical shape, negative zeta potential, and surface hydrophobicity. However, NS displayed a higher ability than NC to interact with the intestinal epithelium, as evidenced by an oral biodistribution study in rats. Moreover, both types of nanocarriers offered similar loading efficiencies and release profiles in simulated fluids. In C. elegans, the encapsulation of quercetin in nanospheres (Q-NS) was found to be two twice more effective than the free form of quercetin in reducing lipid accumulation. For nanocapsules, the presence of wheat germ oil significantly increased the storage of lipids in C. elegans; although the incorporation of quercetin (Q-NC) significantly counteracted the presence of the oil. Finally, nanoparticles improved the oral absorption of quercetin in Wistar rats, offering a relative oral bioavailability of 26% and 57% for Q-NS and Q-NC, respectively, compared to a 5% for the control formulation. Overall, the study suggests that zein nanocarriers, particularly nanospheres, could be useful in improving the bioavailability and efficacy of quercetin.es_ES
dc.description.sponsorshipThis work was partially funded by the Government of Navarra (PC127-128 METANOB). The authors thank the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), for providing C. elegans and E. coli strains.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectNanosphereses_ES
dc.subjectNanocapsuleses_ES
dc.subjectZeines_ES
dc.subjectQuercetines_ES
dc.subjectAntihyperlipidemic effectes_ES
dc.subjectBioavailabilityes_ES
dc.titleZein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetines_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.noteThis is an open access article under the CC BY licensees_ES
dc.identifier.doi10.1016/j.ijpharm.2023.123216-
dadun.citation.publicationNameInternational Journal of Pharmaceuticses_ES
dadun.citation.startingPage123216es_ES
dadun.citation.volume643es_ES
dc.identifier.pmid37423375-

Files in This Item:
Thumbnail
File
1-s2.0-S0378517323006361-main.pdf
Description
Size
4.28 MB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.